In vivo response monitoring of treatment with the epidermal growth factor receptor (EGFR) monoclonal antibody cetuximab in metastatic colorectal cancer: a single centre phase II study.
Phase of Trial: Phase II
Latest Information Update: 28 Feb 2017
At a glance
- Drugs Cetuximab (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms REMOTUX
- 09 Feb 2013 New source identified and integrated (European Clinical Trials Database; EudraCT2009-013279-23).
- 11 Sep 2009 New trial record
- 04 Sep 2009 Status changed to completed as per ISRCTN record.